OBJECTIVES: 1) To measure the proportion of patients with chronic rhinosinusitis (CRS) who experience clinically significant improvement after endoscopic sinus surgery (ESS) in a prospective, multi-institutional fashion. 2) To identify preoperative characteristics that predict clinically significant improvement in quality of life (QOL) after ESS. STUDY DESIGN: Prospective, multi-institutional cohort study. SETTING: Academic tertiary care centers. SUBJECTS AND METHODS: A total of 302 patients with CRS from three centers were enrolled between July 2004 and December 2008 and followed for an average of 17.4 months postoperatively. Preoperative patient characteristics, CT scan, endoscopy score, and pre-and postoperative quality of life (QOL) data were collected. Univariate and multivariate analyses were performed. RESULTS: Patients improved an average of 15.8 percent (18.9 points) on the Rhinosinusitis Disability Index and 21.2 percent (21.2 points) on the Chronic Sinusitis Survey (both P Ͻ 0.001). Patients significantly improved on all eight Medical Outcomes Study Short Form-36 (SF-36) subscales (all P Ͻ 0.001). Among patients with poor baseline QOL, 71.7 percent of patients experienced clinically significant improvement on the RSDI and 76.1 percent on the CSS. Patients undergoing primary surgery were 2.1 times more likely to improve on the RSDI (95% confidence interval [CI], 1.2, 3.4; P ϭ 0.006) and 1.8 times more likely to improve on the CSS (95% CI, 1.1, 3.1; P ϭ 0.020) compared with patients undergoing revision surgery. CONCLUSION: In this prospective, multi-institutional study, most patients experienced clinically significant improvement across multiple QOL outcomes after ESS. Specific patient characteristics provided prognostic value with regard to outcomes.
A ccording to the National Health Interview Survey, chronic rhinosinusitis (CRS) affects 14 percent to 16 percent of the US population and has significant socioeconomic implications, with annual direct costs of $4.3 billion. 1, 2 In addition, the Medical Outcomes Study Short Form-36 (SF-36) general quality-of-life (QOL) instrument has shown that patients with CRS exhibit statistically significant deviations from the general population in several domains. 3 In evaluations using this instrument, patients with sinusitis scored lower in measures of bodily pain and social functioning than patients with congestive heart failure, angina, chronic obstructive pulmonary disease, or back pain. 4 Due to the chronicity of the disease and the relatively poor response of some patients to initial medical therapies, patients with CRS undergo 500,000 surgical procedures annually, with the primary goal of improving QOL. A major goal of our research has been to study patient factors such as standard diagnostic tests or comorbidities that best predict surgical outcomes to aid in preoperative patient counseling and surgical case selection.
Several studies have reported improvement in the large majority of patients undergoing endoscopic sinus surgery (ESS), but these findings have been limited by retrospective data collection or unvalidated outcomes. 5, 6 Some prospective studies have reported improvement in mean QOL and symptom scores following ESS, but the studies did not define the proportion of patients that improved, their results were largely from a single institution, or the sample sizes for analysis were limited. 3, [7] [8] [9] [10] [11] The goal of this study was to report outcomes of ESS using prospective, multi-institutional data from a large cohort and validated disease-specific and general health-related QOL instruments. In addition, preoperative patient factors were evaluated for their ability to predict clinically significant outcomes so that surgeons can appropriately counsel patients and optimize surgical case selection.
Materials and Methods

Study Participants and Data Collection
Adult (Ն18 years) study subjects were enrolled from three performance sites, Oregon Health and Science University (OHSU), the Medical College of Wisconsin (MCW), and Stanford University as part of a multi-institutional prospective cohort study. All patients had a diagnosis of CRS based on the Rhinosinusitis Task Force criteria. 12 Patients were enrolled at the time they elected to undergo ESS after failing broad-spectrum or culture-directed antibiotics in addition to a trial of oral and topical steroid therapy. All study protocols and informed consent were collected and approved by the institutional review boards at each study site.
Demographic data and social history were self-reported by the patient and included age, sex, race and/or ethnicity, annual household income, education level, cigarette use, and alcohol consumption. For the analysis, annual household income was dichotomized to approximate the median US household income (Ͻ$50,000 or Ն$50,000). Heavy alcohol consumption was defined as 14 drinks per week for men and seven drinks per week for women. 13 Presence or absence of clinical characteristics were documented by the physician and included asthma, nasal polyposis, allergies confirmed by testing, acetylsalicylic acid (ASA) intolerance, depression, and history of prior sinus surgery. Preoperative CT scan and preoperative endoscopy examination were scored by a physician who used the Lund-MacKay and Lund-Kennedy scoring systems. Two validated disease-specific instruments, the Rhinosinusitis Disability Index (RSDI, quality of life) and the Chronic Sinusitis Survey (CSS, symptom and medication use), and one validated general health-related QOL instrument, the SF-36, were administered by an experienced research coordinator pre-and postoperatively. 7, 14 In this observational study, the extent of surgery was tailored to the patient's disease process as defined by signs, symptoms, CT scan, and clinical judgment. Sinus mucosal tissue was collected from the ethmoid cavity at the time of surgery.
Statistical Analyses
The objectives of this study were to 1) measure the proportion of patients who experienced clinically significant improvement after ESS in a prospective, multi-institutional fashion, and 2) identify baseline characteristics that were predictive of clinically significant improvement in QOL after ESS.
Clinically significant improvement was defined for each outcome as a change of Ն1/2SD of the baseline QOL score. 15 Using this construct, we defined improvement as a decrease of Ն10.35 points on the RSDI and an increase of Ն9.75 points on the CSS. Improvement was defined for each SF-36 subscale in a similar fashion (Table 1) . To address ceiling effects, patients in the top (best) quintile of QOL scores were removed as a reasonable proxy for patients with baseline scores considered too high to achieve clinically significant improvement; the remaining patients were defined as having poor baseline QOL. Multivariate logistic regression models were created to identify preoperative characteristics that predicted clinically significant improvement after surgery. Baseline variables were first screened to determine potential predictors of QOL improvement. Variables that were predictive on univariate analysis at the P Յ 0.25 level were considered candidate variables for logistic regression modeling. Final models were chosen by using forward selection and backwards elimination stepwise procedures based on P ϭ 0.05 (entry) and P ϭ 0.10 (removal) levels of significance after controlling for age and sex.
Post Hoc Analysis of Sinus Mucosa Specimens
A post hoc analysis was performed on a subset of patients with ethmoid sinus mucosal biopsies performed at the time of surgery at a single institution (OHSU, n ϭ 92). Three histological parameters (eosinophil density, basement membrane thickening, subepithelial edema) and their ability to predict QOL outcomes were examined on the basis of preliminary data and previously published methodology. 16 
Results
Baseline Characteristics of the Cohort
Four hundred thirty-eight patients were enrolled at three sites between July 2004 and December 2008. One hundred thirty-six patients were lost to follow-up because of changes in insurance status, unwillingness to participate, administrative changes, and long-distance travel. Only participants with a minimum of six months postoperative follow-up were included in this analysis. A total of 302 (68.9%) participants from three sites (OHSU, n ϭ 133; MCW, n ϭ 101; and Stanford University, n ϭ 68) were followed for a mean of 17.4 months (SD 6.9) postoperatively. Baseline characteristics of patients in the cohort are described in Table 2 and were compared with those of patients lost to follow-up. Asthma was more prevalent in patients with follow-up (43.4% vs 30.4%; P ϭ 0.010); no other differences were detected between those with follow-up and those lost to follow-up. The frequencies of surgical procedures performed are reported in Table 3 .
Disease-Specific and General Health-Related QOL Improvement after ESS
Mean scores significantly improved on the RSDI (18.9 points or 15.8%; P Ͻ 0.001) and on the CSS (21.2 points or 21.2%; P Ͻ 0.001) ( Table 1) following surgery. SF-36 scores significantly improved across all eight subscales (all P Ͻ 0.001) ( Table 1) .
Among patients with poor baseline QOL, 71.7 percent of patients experienced clinically significant improvement on the RSDI and 76.1 percent of patients experienced clinically significant improvement on the CSS (Fig 1) . Among patients with poor baseline QOL, 32.9 percent to 66.4 percent of patients improved on each of the SF-36 subscales ( Fig 2) .
Patient Characteristic Screening for Prediction of QOL Improvement
RSDI. On univariate screening, sex, education level, and the proportion of patients with asthma, ASA intolerance, and a history of prior sinus surgery were significantly different between those who improved and those who did not improve on the RSDI at the P Յ 0.25 level (Table 4) .
CSS. On univariate screening, age, education level, annual household income, history of prior sinus surgery, and mean preoperative endoscopy score were significantly dif- ferent between those who improved and those who did not improve on the CSS at the P Յ 0.25 level ( Table 5 ).
Sample Size for Construction of the Logistic Regression Models
As part of the initial study design, sample size and power calculations were performed. Logistic regression models of the form:
were used to predict the occurrence of clinically significant improvement, where x represented the independent predictor variable and p was the probability of the event. Approximately 10 events were required for each independent variable to ensure adequate support for logistic regression modeling. The total sample size, n, was based on the formula n ϭ 10q/ min(p( ٙ ),1-p( ٙ )), where p( ٙ ) was an estimate of the probability (p) of the event, and (1-p) was the converse of the probability of the event. Prior to the study, it was estimated that at least 80 percent of patients would improve on the RSDI and CSS; 300 patients supported the modeling of six predictor variables after univariate screening.
Predictors of Disease-Specific QOL Improvement after ESS
The first multivariate logistic regression model examined predictors of clinically significant improvement on the RSDI. After adjustment for age and sex, only a history of prior sinus surgery predicted outcomes: Patients undergoing primary sinus surgery were 2.1 times as likely to improve as patients undergoing revision sinus surgery (95% confidence interval [CI], 1.2, 3.4; P ϭ 0.006) ( Table 6 ). For the variables initially identified on univariate screening, sex, education level, as well as asthma and ASA intolerance, were not significant predictors. The second multivariate logistic regression model examined predictors of clinically significant improvement on the CSS. After adjustment for age and sex, a history of prior sinus surgery predicted less improvement in QOL after ESS. Patients undergoing primary sinus surgery were 1.8 times as likely to improve as patients undergoing revision sinus surgery (95% CI, 1.1, 3.1; P ϭ 0.020) ( Table 6 ). For the variables initially identified on univariate screening, age, education level, annual household income, and endoscopy score were not significant predictors.
Preliminary Findings Regarding Histopathological Predictors of QOL Outcomes
Since our evaluation of various preoperative patient characteristics revealed limited predictive information, we elected to perform a subanalysis on a portion of our cohort from the OHSU enrollment site (with ethmoid mucosa available for review) to evaluate the predictive value of certain histopathological features (n ϭ 92). 9, 16, 17 On post hoc analysis, three histopathological features were examined as potential predictors of QOL outcomes (Table 7) on the basis of prior findings. 9, 16 On univariate screening, 78.7 
Discussion
In this large, multi-institutional, prospective cohort study, 72 percent to 76 percent of patients with CRS and poor baseline QOL experienced clinically significant improvement in disease-specific QOL outcomes after ESS. To help place this within the context of the general medical literature and diverse disease processes, we also found that general health-related QOL was significantly improved after sinus surgery. Clinical factors including asthma, ASA intolerance, and prior sinus surgery as well as preoperative diagnostic testing were found to be important potential predictors of outcomes. However, few of these variables were significant predictors of improvement when multiple risk factors were accounted for in the predictive model. Ultimately, primary ESS patients were twice as likely to improve after surgery as patients undergoing revision ESS, although a baseline measure of disease severity (endoscopy score) was worse in the revision ESS group. Furthermore, preliminary data sug-gested that mucosal eosinophilia and subepithelial edema, present at the time of surgery, may be important factors in predicting QOL outcomes. Prior studies have reported higher proportions of patients experiencing improvement following ESS compared with the current study. In 1994, Terris and Davidson 5 combined 10 primarily retrospective case series from single institutions published between 1989 to 1993. On the basis of this review of articles, the authors reported a 91 percent "improvement rate" following ESS in 1713 patients. The primary outcomes were a retrospective chart review with abstraction of patient results or unvalidated patient survey responses. Resolution of symptoms or decreased episodes of sinusitis were used as indicators of improvement. There was no standard for categorizing preoperative status, extent of disease, or surgical outcomes. With the introduction of both validated disease-specific QOL and general health-related QOL outcome instruments, several centers have reported prospective, single-institution outcomes primarily utilizing mean pre-and postoperative QOL scores to demonstrate the improvements patients experienced with ESS. 9, 10 These studies generally reported improvement in mean QOL scores following ESS but were unable to interpret the clinical relevance of that change or further delineate subgroups of patients who did not experience improvement. Both issues are of critical importance with regard to patient counseling and surgical case selection.
In addition, single-institution studies have been criticized for the potential lack of generalizability to the population of patients undergoing sinus surgery, an issue at least partially addressed by incorporating a multi-institutional study design. In this study, we attempted to address all of these issues to provide a framework for the clinical relevance of a QOL change following ESS, identify subgroups more likely to improve, and include multi-institutional data in our analyses. Defining "clinically significant improvement" with validated QOL instruments is an important means for translating research into meaningful terms that patients can understand and clinicians can factor into shared decision making. This definition is also necessary for building models to predict treatment outcomes. The challenge becomes how to discriminate clinically significant improvement. This investigation utilized improvement of at least 1/2SD of the baseline QOL score to indicate clinically significant change. Interestingly, this construct approximates a patient's ability to detect relevant change in other areas utilizing QOL outcomes and has been described as a "universal" phenomenon in the QOL litera-ture. 15 For comparison with other published literature, we noted that 80.8 percent of patients experienced at least a 50 percent reduction in the duration of symptoms and/or medication use on the CSS; this was nearly identical to the 82 percent reported in a study by Gliklich and Metson. 7 In addition, when considering potential changes in QOL score, one must consider that some patients' preoperative QOL scores were high enough that they were unable to experience clinically significant improvement in QOL. Therefore inclusion of those patients in the analyses resulted in a potentially lower proportion of patients with clinically significant improvement following intervention. We addressed this potential ceiling effect by performing one analysis that included all patients and a secondary analysis that excluded patients in the top quintile of preoperative QOL scores. The results from the predictive models were similar. Ultimately, translating data into clinically meaningful terms will assist clinicians in providing realistic expectations to patients, but determining the best definition for reporting clinically significant change continues to be an area of investigation.
Several clinical factors including comorbidities such as asthma or ASA intolerance, prior sinus surgery, and diagnostic testing including endoscopy score were significant in the univariate screening of potential predictors of QOL outcomes. These clinical factors have been studied elsewhere in the literature and have been shown to impact outcomes. 18, 19 Demographic characteristics including sex, annual household income, and education level were also important in univariate screening and have been studied by us and others in the general QOL literature. 20 Surprisingly, when we accounted for all of these patient factors (comorbidities, diagnostic tests, and demographic characteristics) in our predictive model, very few patient factors were found to be predictive of outcomes of ESS. Whether patients were undergoing primary or revision surgery was clearly predictive such that the chances of QOL improvement were twice as high for primary surgery compared with revision surgery. Therefore, patient characteristics discernable on presentation for sinus surgery or "clinical phenotype" did not provide the predictive information we sought. This led us to investigate other factors that may have predictive importance. On the basis of several studies, it appears that inflammation is an important factor in determining treatment outcomes. 9, 10, 18, 19 In following this concept of inflammatory status predicting outcomes, we began to examine our cohort for other indicators of inflammation that have been suggested to predict outcomes. 9, 16, 17 Specifically, markers of inflammation present in the sinus mucosa may provide predictive information regarding outcomes on the basis of their ability to discriminate the severity of the inflammatory process. In a post hoc analysis, our preliminary focus on histological markers of inflammation in the sinonasal mucosa revealed the finding of heterogeneity within clinical phenotypes (e.g., CRS with polyps) with regard to the presence of inflammatory markers and outcomes of treatment. 16 When evaluated using predictive models, mucosal eosinophil density and subepithelial edema appeared to provide predictive information such that patients with lower eosinophil density or less subepitheilial edema were two to four times more likely to improve with ESS. The observational nature of this study and the routine use of perioperative cointerventions, including systemic steroids that are thought to impact the expression of these markers, should be considered in the context of these results. Future investigations should continue to evaluate histological and molecular inflammatory markers in a more controlled fashion for their utility in defining disease and predicting treatment outcomes. If found to be an important determinant of outcome, inflammatory marker evaluation through preoperative mucosal sampling might play a role in future patient counseling regarding outcomes of sinus surgery.
Conclusion
In this prospective, multi-institutional cohort study, the majority of patients experienced clinically significant improvement in QOL outcomes with ESS. Certain clinical phenotypes, such as CRS associated with asthma, CRS associated with ASA intolerance, and CRS associated with prior sinus surgery, were significant in the univariate screening of predictors of QOL outcomes; however, among these phenotypes, history of prior sinus surgery appears to be most predictive. In addition, standard diagnostic tests such as endoscopy were significant in the univariate screening of potential predictors of QOL outcomes, but not significant in the final predictive models. Finally, preliminary analyses suggested that mucosal inflammatory markers provide im-portant predictive information and deserve further investigation.
